# Novel Rapid POC Diagnostics for COVID-19

> **NCT05438589** · — · COMPLETED · sponsor: **Foundation for Innovative New Diagnostics, Switzerland** · enrollment: 1283 (actual)

## Conditions studied

- COVID-19 Respiratory Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05438589
- **Lead sponsor:** Foundation for Innovative New Diagnostics, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-25
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-02-28
- **Target enrollment:** 1283 (ACTUAL)
- **Last updated:** 2023-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05438589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05438589, "Novel Rapid POC Diagnostics for COVID-19". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05438589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*